Investigación

Leucemia y hemopatías pediátricas

Buscador de publicaciones

Publicaciones

  • Salmerón-Villalobos J, Ramis-Zaldivar JE, Balagué O, Verdú-Amorós J, Celis-Passini V, Sábado C, Garrido M, Mato S, Uriz J, Ortega MJ, Gutierrez-Camino A, Sinnett D, Illarregi U, Carron M, Regueiro A, Galera A, Gonzalez-Farré B, Campo E, Garcia N, Colomer D, Astigarraga I, Andrés M, Llavador M, Martin-Guerrero I and Salaverria I.

    Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma

    PEDIATRIC BLOOD & CANCER . 69(11): . Nº de citas: 7

    [doi:10.1002/pbc.29926]

  • Kotmayer L, Romero-Moya D, Marin-Bejar O, Kozyra E, Català-Temprano A, Bigas A, Wlodarski MW, Bödör C and Giorgetti A.

    GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects

    BRITISH JOURNAL OF HAEMATOLOGY . 199(4): 482-495. Nº de citas: 13

    [doi:10.1111/bjh.18330]

  • Núñez R, Álvarez-Román MT, Bonanad S, González-Porras JR, De La Corte-Rodriguez H, Berrueco R and Jiménez-Yuste V.

    The Limitations and Unmet Needs of the Five Cornerstones to Guarantee Lifelong Optimization of Prophylaxis in Hemophilia Patients.

    th open : companion journal to thrombosis and haemostasis . 6(4): 365-377. Nº de citas: 1

    [doi:10.1055/s-0042-1757745]

  • Hinojosa J, Simó-Nebot M, Armero-Campos G, Becerra MV, Alamar AM, Candela-Cantó SA, Culebras D, Muchart-Lopez J and Berrueco R.

    Hemophilia and non-accidental head trauma in two siblings: lessons and legal implications

    CHILDS NERVOUS SYSTEM . 38(12): 2415-2423.

    [doi:10.1007/s00381-022-05713-2]

  • Ghorashian S, Jacoby E, De Moerloose B, Rives-Solà S, Bonney D, Shenton G, Bader P, Bodmer N, Quintana AM, Herrero B, Algeri M, Locatelli F, Vettenranta K, Gonzalez B, Attarbaschi A, Harris S, Bourquin JP and Baruchel A.

    Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study

    LANCET HAEMATOLOGY . 9(10): 766-775. Nº de citas: 23

    [doi:10.1016/S2352-3026(22)00225-3]

  • Fernandez-Sojo J, Horton R, Cid J, Azqueta C, Garcia-Buendia A, Valdivia E, Martorell L, Rubio-Lopez N, Codinach M, Aran G, Marsal-Ricoma J, Mussetti A, Martino R, Diaz-de-Heredia C, Ferra C, Valcarcel D, Linares M, Ancochea A, Garcia-Rey E, García-Muñoz N, Medina L, Carreras E, Villa J, Lozano M, Gibson D and Querol S.

    Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry

    BONE MARROW TRANSPLANTATION . 57(10): 1531-1538. Nº de citas: 6

    [doi:10.1038/s41409-022-01750-2]

  • Solsona M, Berrueco R, Sebastián E, Cervera A, Sastre A, Astigarraga I, Argilés B, Dasí MA, Dapena JL and Monteagudo E.

    Tapering of the thrombopoietin receptor agonist in paediatric patients with chronic immune thrombocytopenia: Is it possible?

    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . 88(9): 4220-4223.

    [doi:10.1111/bcp.15378]

  • Ortigoza-Escobar JD, Fernández de Sevilla-Estrach M, Monfort L, Anton-Lopez J, Iglesias-Jimenez E, Rebollo M, Del Prado-Sanchez C, Arostegui JI, Mensa-Vilaró A, Alsina L, Rodriguez-Vigil Iturrate C, Niemeyer CM, Jou-Munoz C and Català-Temprano A.

    Cytokine profile and brain biopsy in a case of childhood-onset central nervous system vasculitis in Noonan syndrome-like disorder due to a novel CBL variant

    JOURNAL OF NEUROIMMUNOLOGY . 369: 577917-577917. Nº de citas: 3

    [doi:10.1016/j.jneuroim.2022.577917]

  • Ramos-Muntada M, Trincado JL, Blanco J, Bueno C, Rodríguez-Cortez VC, Bataller A, López-Millán B, Schwab C, Ortega M, Velasco P, Blanco ML, Nomdedeu J, Ramírez-Orellana M, Minguela A, Fuster JL, Cuatrecasas E, Camós-Guijosa M, Ballerini P, Escherich G, Boer J, denBoer M, Hernández-Rivas JM, Calasanz MJ, Cazzaniga G, Harrison CJ, Menéndez P and Molina O.

    Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

    MOLECULAR ONCOLOGY . 16(16): 2899-2919. Nº de citas: 5

    [doi:10.1002/1878-0261.13276]

  • Megías-Vericat JE, Bonanad Boix S, Berrueco R, Mingot-Castellano ME, Rodríguez López M, Canaro Hirnyk M, Mateo Arranz J, Calvo Villas JM, Haya Guaita S, Mesegue-Meda M, López Jaime F, Albo-López C, Palomero-Massanet A, Vilalta Seto N, Leciñena IL, Haro ARC and Poveda Andrés JL.

    Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products

    THROMBOSIS RESEARCH . 216: 35-42. Nº de citas: 5

    [doi:10.1016/j.thromres.2022.06.001]